Would subsidizing weight-loss drugs make health care fairer?
GLP-1 medicines such as Ozempic, Wegovy and Mounjaro have transformed the treatment of obesity, but access to them in Australia increasingly depends on something much less medical: whether you can afford them.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery
United Kingdom
-
Rice, fish and pickles: Is the traditional Japanese diet as healthy as we think?
United Kingdom
-
Five at-home strength moves that can make everyday tasks easier
United Kingdom
-
Scientists found a link between Mediterranean diet blood markers and longer survival
United Kingdom
-
Fitness tracker data could offer clues about future brain health
United Kingdom
-
A 20-year study of 90,000 adults suggests the type of fish you eat matters
United Kingdom
-
Researchers warn of growing threats to sleep health across Europe
United Kingdom
-
Nearly 1.6 million pounds of hot dogs, bacon and deli meats recalled after cooler failure
United Kingdom